Physician profile
Eric Royster
NPI 1851582795
$10,124.81
in general payments reported to CMS, 2019-2025
50 companies · $990 in 2025
The $990 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $1,159 · 2021: $1,663 · 2022: $1,359 · 2023: $2,286 · 2024: $1,323 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,100 · Grant: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,099.70 |
| Grant | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,625.65 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Collegium Pharmaceutical, INC. | $1,021.36 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $899.26 | 2019-2025 | Relistor |
| Abbott Laboratories | $889.51 | 2019-2024 | Eterna, Proclaim |
| Medtronic USA, INC. | $677.79 | 2019-2020 | |
| Pfizer INC. | $658.02 | 2019-2024 | |
| Medtronic, INC. | $629.50 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $579.58 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $271.76 | 2019-2025 | Ztlido |
| Biohaven Pharmaceuticals, INC. | $257.40 | 2021 | |
| Amgen INC. | $234.49 | 2019-2022 | |
| Lundbeck LLC | $226.32 | 2020-2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company Ltd. | $221.19 | 2022 | |
| Biodelivery Sciences International, INC. | $183.23 | 2019-2021 | |
| Forte Bio-Pharma LLC | $164.13 | 2019-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Royster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.